Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Current Opinion in Oncology|July 15, 2022
Management of epilepsy in brain tumor patientsPim B van der Meer, Martin J B Taphoorn, Johan A F KoekkoekEpilepsia|November 16, 2022
First-line levetiracetam versus enzyme-inducing antiseizure medication in glioma patients with epilepsyPim B van der Meer, Marta Maschio, Linda Dirven, et al.Neuro-Oncology Practice|September 30, 2021
Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic reviewMarjolein E de Bruin, Pim B van der Meer, Linda Dirven, et al.Journal of Neuro-Oncology|April 6, 2021
Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaintsPim B van der Meer, Johan A F Koekkoek, Martin J van den Bent, et al.Neuro-Oncology Practice|June 9, 2025
Seizure outcomes in patients with brain metastases and epilepsy: a systematic review on the efficacy of antitumor treatment and antiseizure medicationJosien C C Scheepens, Pim B van der Meer, Linda Dirven, et al.Neuro-Oncology Practice|July 17, 2023
Depression and anxiety in glioma patientsPim B van der Meer, Linda Dirven, Caroline Hertler, et al.Neuro-Oncology Practice|April 4, 2022
Prescription preferences of antiepileptic drugs in brain tumor patients: An international survey among EANO membersPim B van der Meer, Linda Dirven, Martin J van den Bent, et al.Epilepsia|March 18, 2021
First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acidPim B van der Meer, Linda Dirven, Marta Fiocco, et al.Neurology|February 8, 2023
Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort StudyPim B van der Meer, Linda Dirven, Marta Fiocco, et al.Neurology|October 11, 2022
Effectiveness of Antiseizure Medication Duotherapies in Patients With Glioma: A Multicenter Observational Cohort StudyPim B van der Meer, Linda Dirven, Marta Fiocco, et al.Pageof 9